Company / Operating Cash Flow per Share
IGC Pharma, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.06
FY2025
5-year range
-$0.23 / -$0.06
FY2021-FY2025
Trend
+55.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.23 in FY2022 to $-0.06 in FY2025.
Based on SEC 10-K filings.
-0.06 in FY2025.
Improved from $-0.15 to $-0.06 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 55.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.06 | +55.3% |
| FY2024 | -$0.13 | +9.2% |
| FY2023 | -$0.15 | +35.3% |
| FY2022 | -$0.23 | -2.3% |
| FY2021 | -$0.22 | -161.8% |
| FY2020 | -$0.08 | -34.3% |
| FY2019 | -$0.06 | -27.6% |
| FY2018 | -$0.05 | -625.9% |
| FY2017 | -$0.01 | +99.7% |
| FY2016 | -$1.99 | -48.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026